Content TV

+

Controversies in atrioventricular valves - The Heart Team ring, Vol II - PCR London Valves 2023

Controversies in atrioventricular valves - Heart Team ring, Vol II

This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Watch discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Cleveland Clinic’s Porcine vs. Bovine Outcomes

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar on the latest clinical outcomes on PFO

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline

Controversies in atrioventricular valves - Heart Team ring, Vol II

Related Videos

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Early outcomes on Epic Max platfrom

Webinar PFO closure in patients >60 Years

CONNEXT

TCT 21: EXPAND G4

Tendyne™: 6-Year Outcomes

Amplatzer™ Valvular Plug III – HCP

EuroEcho 2021: MR Treatment (Evidence)

CONNEXT

Now you've got Navitor. Stable delivery.

Now you've got Navitor

Pre-term PDA cases

LAAO Summit - TEE vs CT leaks

Now you've got Navitor.
Stable delivery.